Stock Events

Medical Developments International 

$0.35
0
+$0+0% Wednesday 19:22

Statistics

Day High
0.31
Day Low
0.31
52W High
0.71
52W Low
0.29
Volume
2,500
Avg. Volume
337
Mkt Cap
29.86M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

29AugExpected
Q4 2021
Q2 2022
Q4 2022
Q2 2023
Q4 2023
Q1 2024
Next
-0.1
-0.09
-0.08
-0.07
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MDDVF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson operates in the pharmaceuticals sector, directly competing in various healthcare markets including pain management, where Medical Developments International is active with its non-opioid pain relief product.
Pfizer
PFE
Mkt Cap169.83B
Pfizer is a global pharmaceutical company that competes in the development and marketing of medications and vaccines for a wide range of conditions, including those in pain management, a key area for Medical Developments International.
Novartis
NVS
Mkt Cap232.42B
Novartis is a multinational pharmaceutical company that produces drugs in many of the same therapeutic areas as Medical Developments International, including analgesics for pain management.
Abbvie
ABBV
Mkt Cap304.29B
AbbVie operates in the pharmaceuticals industry, focusing on areas including chronic pain management, where it competes with Medical Developments International's offerings.
GSK
GSK
Mkt Cap81.55B
GlaxoSmithKline is a global healthcare company that develops and markets drugs and vaccines, including for pain relief, making it a competitor in the same market as Medical Developments International.
Merck &
MRK
Mkt Cap318.55B
Merck & Co., Inc. is involved in the development, manufacturing, and marketing of drugs across various therapeutic areas, including pain management, competing with Medical Developments International.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap19.04B
Teva Pharmaceutical Industries is a global company that manufactures generic and specialty medicines, including pain management solutions, competing with Medical Developments International's products.
Bristol-Myers Squibb
BMY
Mkt Cap86.44B
Bristol Myers Squibb is a global biopharmaceutical company that develops medicines in several therapeutic areas, including pain, directly competing with Medical Developments International.
Sanofi
SNY
Mkt Cap128.21B
Sanofi is a global pharmaceutical company that offers a broad range of medicines, including those for pain management, competing with Medical Developments International.
Astrazeneca
AZN
Mkt Cap244.04B
AstraZeneca is a global, science-led biopharmaceutical business that operates in many of the same therapeutic areas as Medical Developments International, including pain management.

About

Health Technology
Medical Specialties
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease; Penthrox, a trauma and emergency pain relief product; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, oxygen resuscitation kits, oxygen therapy masks, and resuscitators. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.
Show more...
CEO
Country
AU
ISIN
AU000000MVP2

Listings